Suppr超能文献

革兰氏阴性杆菌菌血症治疗中的抗菌协同作用。

Antimicrobial synergism in the therapy of gram-negative rod bacteremia.

作者信息

Anderson E T, Young L S, Hewitt W L

出版信息

Chemotherapy. 1978;24(1):45-54. doi: 10.1159/000237759.

Abstract

To determine if antimicrobial synergism might affect the results of treatment of gram-negative rod infections, 444 bacteremias from 1972 through 1974 were studied. On these, 173 were treated with two antibiotics to which the infecting organisms were sensitive. Clinical responses were observed in 80% of 83 cases where antibiotic activity was synergistic, as defined by a minimum inhibitory concentration (MIC) of each antibiotic in combination being one-fourth or less than the MICs of individual drugs. This response rate was significantly better than the 64% response seen in patients treated with nonsynergistic combinations (p less than 0.05). Synergism correlated with significantly better clinical responses in those patients with "rapidly fatal" and "ultimately fatal" underlying disease (p less than 0.005), neutropenia (p less than 0.001), shock (p less than 0.01) and Pseudomonas aeruginosa infections (p less than 0.05). These results suggest that the use of antibiotic combinations to treat patients with gram-negative rod bacteremia who have the poorest prognosis is clinically justified and the improved results may be related to the synergistic activity of antimicrobial agents.

摘要

为确定抗菌协同作用是否会影响革兰氏阴性杆菌感染的治疗结果,对1972年至1974年间的444例菌血症进行了研究。其中,173例接受了针对感染菌敏感的两种抗生素治疗。在83例抗生素活性具有协同作用的病例中,80%观察到了临床反应,协同作用的定义为每种抗生素联合使用时的最低抑菌浓度(MIC)为单个药物MIC的四分之一或更低。这一反应率显著高于接受非协同组合治疗患者的64%的反应率(p<0.05)。在患有“快速致命”和“最终致命”基础疾病(p<0.005)、中性粒细胞减少(p<0.001)、休克(p<0.01)和铜绿假单胞菌感染(p<0.05)的患者中,协同作用与显著更好的临床反应相关。这些结果表明,使用抗生素联合治疗预后最差的革兰氏阴性杆菌菌血症患者在临床上是合理的,改善的结果可能与抗菌药物的协同活性有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验